Michael McNevin is the Director of Vaccine Analytical Research and Development at Merck, where they focus on biophysical characterization of vaccine clinical candidates and related products. Previously, they served as a Principal Scientist specializing in molecular and materials characterization, leading a skilled team to enhance the stability and formulation of vaccines. With a Ph.D. in Chemistry from the University of Colorado at Boulder and extensive experience in biopharmaceutical development, Michael combines scientific leadership with technical expertise in the field. Their early career included managing the Crystallography Facility at the University of Colorado, contributing to structural elucidation and technology development.
This person is not in any teams
This person is not in any offices